Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy

References

• BurgerHGThe endocrinology of the menopauseMaturitas19962321291368735351
   PubMed Web of Science ®Google Scholar
• GoldEBColvinAAvisNLongitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nationAm J Public Health20069671226123516735636
   PubMed Web of Science ®Google Scholar
• Mac BrideMBRhodesDJShusterLTVulvovaginal atrophyMayo Clin Proc2010851879420042564
   PubMed Web of Science ®Google Scholar
• RiggsBLKhoslaSMeltonLJIIIA unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging menJ Bone Miner Res19981357637739610739
   PubMed Web of Science ®Google Scholar
• LewisVUndertreatment of menopausal symptoms and novel options for comprehensive managementCurr Med Res Opin200925112689269819775194
   PubMed Web of Science ®Google Scholar
• National Osteoporosis FoundationFast Facts on Osteoporosis2010 Available from: http://www.nof.org/node/40Accessed November 17, 2011
   Google Scholar
• UtianWHPsychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewHealth Qual Life Outcomes200534716083502
   PubMedGoogle Scholar
• SucklingJLethabyAKennedyRLocal oestrogen for vaginal atrophy in postmenopausal womenCochrane Database Syst Rev20064CD00150017054136
   PubMedGoogle Scholar
• SwansonSGDrosmanSHelmondFAStathopoulosVMTibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled studyMenopause200613691792517006377
   PubMed Web of Science ®Google Scholar
• North American Menopause SocietyManagement of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause SocietyMenopause2010171255420061894
   PubMed Web of Science ®Google Scholar
• North American Menopause SocietyEstrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause SocietyMenopause201017224225520154637
   PubMed Web of Science ®Google Scholar
• VoigtLFWeissNSChuJDalingJRMcKnightBvan BelleGProgestagen supplementation of exogenous oestrogens and risk of endometrial cancerLancet199133887622742771677110
   PubMed Web of Science ®Google Scholar
• WeiderpassEAdamiHOBaronJARisk of endometrial cancer following estrogen replacement with and without progestinsJ Natl Cancer Inst199991131131113710393721
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• RolnickSJKopherRADeForTAKelleyMEHormone use and patient concerns after the findings of the Women’s Health InitiativeMenopause200512439940416037754
   PubMed Web of Science ®Google Scholar
• KharodeYBodinePVMillerCPLyttleCRKommBSThe pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis preventionEndocrinology2008149126084609118703623
   PubMed Web of Science ®Google Scholar
• KommBSLyttleCRDeveloping a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluationAnn N Y Acad Sci200194931732611795370
   PubMed Web of Science ®Google Scholar
• KommBSKharodeYPBodinePVHarrisHAMillerCPLyttleCRBazedoxifene acetate: a selective estrogen receptor modulator with improved selectivityEndocrinology200514693999400815961563
   PubMed Web of Science ®Google Scholar
• BerrodinTJChangKCKommBSFreedmanLPNagpalSDifferential biochemical and cellular actions of premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combinationMol Endocrinol2009237585
   Google Scholar
• ChangKCNWangYBodinePVNagpalSKommBSGene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogensJ Steroid Biochem Mol Biol20101181–211712419914376
   PubMed Web of Science ®Google Scholar
• CrabtreeJSPeanoBJZhangXKommBSWinnekerRCHarrisHAActivity of three selective estrogen receptor modulators on hormonedependent responses in the mouse uterus and mammary glandMol Cell Endocrinol20082871–2404618367319
   PubMed Web of Science ®Google Scholar
• PeanoBJCrabtreeJSKommBSWinnekerRCHarrisHAEffects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary glandEndocrinology200915041897190319022889
   PubMed Web of Science ®Google Scholar
• KommBSVlasserosFSamadfamRChouinardLSmithSYSkeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized ratsBone201149337638621658483
   PubMed Web of Science ®Google Scholar
• LoboRAPinkertonJVGassMLEvaluation of bazedoxifene/ conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profileFertil Steril20099231025103819635615
   PubMed Web of Science ®Google Scholar
• ArcherDFLewisVCarrBROlivierSPickarJHBazedoxifene/ conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenFertil Steril20099231039104419635614
   PubMed Web of Science ®Google Scholar
• LindsayRGallagherJCKaganRPickarJHConstantineGEfficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal womenFertil Steril20099231045105219635616
   PubMed Web of Science ®Google Scholar
• PickarJHYehI-TBachmannGSperoffLEndometrial effects of a tissue selective estrogen complex containing bazedoxifene/ conjugated estrogens as a menopausal therapyFertil Steril20099231018102419635613
   PubMed Web of Science ®Google Scholar
• PinkertonJVUtianWHConstantineGDOlivierSPickarJHRelief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trialMenopause20091661116112419546826
   PubMed Web of Science ®Google Scholar
• KaganRWilliamsRSPanKMirkinSPickarJHA randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenMenopause201017228128919779382
   PubMed Web of Science ®Google Scholar
• DreyerPVieiraJGBone turnover assessment: a good surrogate marker?Arq Bras Endocrinol Metabol20105429910520485896
   PubMedGoogle Scholar
• MandelsonMTOestreicherNPorterPLBreast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancersJ Natl Cancer Inst200092131081108710880551
   PubMedGoogle Scholar
• McCormackVAdos Santos SilvaIBreast density and parenchymal patterns as markers of breast cancer risk: a meta-analysisCancer Epidemiol Biomarkers Prev20061561159116916775176
   PubMed Web of Science ®Google Scholar
• HarveyJAPinkertonJVBaracatECShiHMirkinSChinesAAEvaluation of changes in mammographic breast density associated with bazedoxifene/conjugated estrogens in postmenopausal womenEndocr Rev2011323P1P79
   Google Scholar
• PinkertonJAConstantineGDKommBSYuHPickarJHBreast effects of bazedoxifene/conjugated estrogens in a randomized, controlled trial of postmenopausal womenPoster presented at: The 19th Annual Meeting of the North American Menopause SocietySeptember 24–27, 2008Lake Buena Vista, FL, USA2008 Abstract P-46
   Google Scholar
• PinkertonJVTaylorHPanKChinesAMirkinSBreast parameters with bazedoxifene/conjugated estrogens in randomized, controlled trials of postmenopausal womenMenopause201017612211222
   Web of Science ®Google Scholar
• SpencerCPGodslandIFStevensonJCIs there a menopausal metabolic syndrome?Gynecol Endocrinol19971153413559385535
   PubMed Web of Science ®Google Scholar
• KronenbergFHot flashes: phenomenology, quality of life, and search for treatment optionsExp Gerontol1994293–43193367925752
   PubMed Web of Science ®Google Scholar
• PinkertonJVChinesAARacketaJMirkinSBazedoxifene/conjugated estrogens (BZA/CE): effect on sleep parameters in postmenopausal womenMenopause201017612371238
   Web of Science ®Google Scholar
• UtianWYuHBobulaJMirkinSOlivierSPickarJHBazedoxifene/ conjugated estrogens and quality of life in postmenopausal womenMaturitas200963432933519647382
   PubMed Web of Science ®Google Scholar
• PinkertonJVChinesAARacketaJMirkinSMenopause-related quality of life and satisfaction in postmenopausal women treated with bazedoxifene/conjugated estrogens (BZA/CE)Menopause20101761219
   Web of Science ®Google Scholar
• BachmannGBobulaJMirkinSEffects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophyClimacteric201013213214019863455
   PubMed Web of Science ®Google Scholar
• TopalNBAyhanSTopalUBilginTEffects of hormone replacement therapy regimens on mammographic breast density: the role of progestinsJ Obstet Gynaecol Res200632330530816764621
   PubMed Web of Science ®Google Scholar
• MartinLJMinkinSBoydNFHormone therapy, mammographic density, and breast cancer riskMaturitas2009641202619709825
   PubMed Web of Science ®Google Scholar
• FreedmanMSan MartinJO’GormanJDigitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placeboJ Natl Cancer Inst2001931515611136842
   PubMedGoogle Scholar
• BarnabeiVMCochraneBBAragakiAKMenopausal symptoms and treatment-related effects of estrogen and progestin in the Women’s Health InitiativeObstet Gynecol20051051063107315863546
   PubMed Web of Science ®Google Scholar
• LoboRABushTCarrBRPickarJHEffects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolismFertil Steril2001761132411438314
   PubMed Web of Science ®Google Scholar
• HaysJOckeneJKBrunnerRLEffects of estrogen plus progestin on health-related quality of lifeN Engl J Med2003348191839185412642637
   PubMed Web of Science ®Google Scholar
• BrunnerRLGassMAragakiAEffects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women’s Health Initiative Randomized Clinical TrialArch Intern Med2005165171976198616186467
   PubMedGoogle Scholar
• Polo-KantolaPErkkolaRHeleniusHIrjalaKPoloOWhen does estrogen replacement therapy improve sleep quality?Am J Obstet Gynecol19981785100210099609575
   PubMed Web of Science ®Google Scholar
• BarnabeiVMGradyDStovallDWMenopausal symptoms in older women and the effects of treatment with hormone therapyObstet Gynecol200210061209121812468165
   PubMed Web of Science ®Google Scholar
• GelfandMMMoreauMAyotteNJHilditchJRWongBALauCYClinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled studyMenopause2003101293612544674
   PubMed Web of Science ®Google Scholar
• HlatkyMABoothroydDVittinghoffESharpPWhooleyMAQuality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/ Progestin Replacement Study (HERS) trialJAMA2002287559159711829697
   PubMed Web of Science ®Google Scholar
• HainesCJYimSFChungTKA prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese womenMaturitas200344320721412648884
   PubMed Web of Science ®Google Scholar